Vancouver-based technology company GBT Technologies Inc. (OTCPINK:GTCH) has announced that it is expanding its Avant! AI platform through its subsidiary, GBT Tokenize LLC. The Avant! AI platform is a proprietary artificial intelligence system that uses machine learning algorithms to analyze data and provide insights to businesses. The expansion will focus on developing the platform’s natural language processing capabilities, allowing it to better understand and interpret human language.
GBT Technologies CEO, Danny Rittman, said, “We believe that natural language processing is a key component of any successful AI platform, and we are excited to be expanding our capabilities in this area. Our goal is to create an AI system that can understand and interpret human language in a way that is as close to human-like as possible.”
The company’s Avant! AI platform is already being used by a number of businesses in various industries, including healthcare, finance, and retail. The platform is designed to help businesses make better decisions by providing them with insights based on data analysis.
In other AI news, medical technology company Nevro Corp. (NYSE:NVRO) has announced that it is partnering with AI startup Viz.ai to develop an AI-powered platform for stroke detection and treatment. The platform will use machine learning algorithms to analyze medical images and provide real-time insights to doctors, allowing them to make faster and more accurate diagnoses.
The partnership is part of Nevro’s broader strategy to incorporate AI into its medical devices and services. The company’s CEO, Keith Grossman, said, “We believe that AI has the potential to revolutionize the way we diagnose and treat medical conditions, and we are excited to be at the forefront of this innovation.”
